Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Culper Research is an activist short-selling firm that specializes in investigative research on publicly traded companies to identify instances of fraud, mismanagement, and financial misrepresentation. Founded in 2019 by Christian Lamarco and based in New York, the firm has gained significant notoriety for its critical reports on companies within the healthcare and biotechnology sectors. Culper Research typically takes a short position in the entities it investigates, publishing detailed dossiers to alert investors to perceived risks, such as manipulated clinical trial data or undisclosed related-party transactions. Notable targets of the firm's research have included ADMA Biologics, Cassava Sciences, and Ginkgo Bioworks. The firm's work is characterized by deep-dive forensic accounting and on-the-ground investigative techniques aimed at exposing corporate malfeasance.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Culper Research.